Medical Writing Preclinical Studies Nonclinical studies in the Russian Federation — Problems, regulatory norms, and harmonisation with international standards

Volume 26, Issue 4 - Preclinical Studies

Nonclinical studies in the Russian Federation — Problems, regulatory norms, and harmonisation with international standards

Abstract

Drug product developers and sponsors face a number of problems when organising a nonclinical study in Russia, especially, the diverse range of standards and few certified animal breeding centres, complicating adaptation of the available experimental data to domestic legislation. In this article, we discuss the main regulatory documents in Russia, their compliance with international standards (Good Laboratory Practice), the structure of the responsible authorities, and problems with implementing the regulatory documents. Finally, we discuss the current regulatory trends in Russian nonclinical studies.
Download the full article

References

  1. Russian Federation Federal Law no. 61-FZ “On Circulation of Medicines” dated April 12, 2010. Available from: https://www.unodc.org/res/cld/ document/rus/federal-law-on-circulationof- medicines_ html/Russian_Federation_ Federal_Law_On_ Circulation_of_ Medicines_61-FZvEN.pdf
  2. Decree no. 2603-r dated December 28, 2012 [cited October 13, 2017]. Available from: http://docs. cntd.ru/document/ 902392511
  3. Decision no. 2067-r dated November 8, 2013 [cited October 13, 2017]. Available from: http://docs.cntd.ru/document/ 499056249
  4. Decision no. 1172 dated December 17, 2013 [cited October 13, 2017]. Available from: http://docs.cntd.ru/document/ 499065307
  5. Decree of the Ministry of Industry and Trade of the Russian Federation no. 965 dated October 23, 2009 [cited October 13, 2017]. Available from: http://docs.cntd.ru/ document/902186334
  6. “Guidelines for the Testing of Chemicals”, 2014 [cited October 13, 2017]. Available from: http://docs.cntd.ru/search/ intellectual/q/Методы+испытания+по+ воздействию+химической+продукции+ на+организм+человека/r/1
  7. Decree no. 199 n “On approval of the principles of Good Laboratory Practice” dated April 1, 2016 [cited October 13, 2017]. Available from: http://docs.cntd.ru/ document/420350679
  8. National standard of the Russian Federation GOST R 53434-2009 “The principles of Good Laboratory Practice” dated April 1, 2016 [cited October 13, 2017]. Available from: http://docs.cntd.ru/ document/1200075972
  9. Mironov AN, editor. Guidelines for Preclinical Trials of Medicinal Products. Part 1. Moscow: Grif i K; 2012. Available from: http://
  10. Mironov AN, editor. Guidelines for Preclinical Trials of Medicinal Products. Part 2. Moscow: Grif i K; 2012. Available from: http://
  11. Federal Law “On amendment of the Federal Law ‘On Circulation ofMedicines’” no. 429-FZ dated December 22, 2014 [cited October 13, 2017]. Available from: http://pravo.gov.ru/proxy/ips/?docbody= &firstDoc=1&lastDoc=1&nd=102364596
  12. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments,J Pharmacol Exp Ther. 1949;96(2):99–113. Available from: http://
  13. Lim RK, Rink KG, Glass HG Soaje- Echague E. A method for the evaluation of cumulation and tolerance by the determination of acute and subchronic median effective doses. Arch Intern Pharmacodyn. 1961;130:336 –53. Available from: http://
  14. Guidance on expert assessment of the medicinal products. V. 1-4; 2013-2014. Available from: http://fptl.ru/ biblioteka/razrabotka-i-ekspertizalekarstv. html
  15. GOST 33647-2015 “Principles of good laboratory practice (GLP). Terms and definitions”, 2015 [cited October 13, 2017]. Available from: http://docs.cntd.ru/ document/1200129061

Search

Articles

Preclinical studies
President’s Message
EMWA celebrates 25 years
EMWA News
Preclinical research in drug development
An introduction to little-known aspects of nonclinical regulatory writing
Reporting of preclinical research: What do we get told – when and how?
Mind the gap – towards complete and transparent reporting of animal research
The reproducibility crisis in preclinical research – lessons to learn from clinical research
Nonclinical studies in the Russian Federation — Problems, regulatory norms, and harmonisation with international standards
How to survive Brexit as an independent medical writer
Creation of a patient-centric patient lay summary in the local language
Six communication rules for scientific presentations and writing
So, you want to be a medical journalist?
News from the EMA
Profile: An interview with Steven Walker
Getting Your Foot in the Door
In the Bookstores
Journal Watch
The Webscout
Good Writing Practice
Medical Communications
Out on Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief

Raquel Billiones

Co-Editors

Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir

AI/Automation

Jennifer Bell

Biotechnology

Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer

Publications

Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha

Out on Our Own

Tiziana von Bruchhausen

Pharmacovigilance

Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk